日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis

BASDAI 和 ASDAS 疾病状态与 ASAS40 反应的关系：ixekizumab 治疗放射学轴性脊柱关节炎的事后分析

期刊:Rheumatology Advances in Practice
影响因子:2.1
doi:10.1093/rap/rkaf012
Rudwaleit, Martin; Navarro-Compán, Victoria; Russ, Hagen; Panni, Tommaso; Filippi, Erica; Nassab, Mani Haschemi; Liu-Leage, Soyi; Goëb, Vincent; Ciccia, Francesco; Dudler, Jean
关节炎
发表日期：2025
文献求助 收藏

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

早期临床反应与放射学轴性脊柱关节炎患者接受ixekizumab治疗的长期疗效相关

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004429
Ramiro, Sofia; Lukas, Cédric; Bessette, Louis; Wickersham, Pendleton; Panni, Tommaso; Bolce, Rebecca; Liu-Leage, Soyi; Janos, Boris; Nissen, Michael J; Wei, James Cheng-Chung
关节炎
发表日期：2024
文献求助 收藏

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study

轴性脊柱关节炎患者停用ixekizumab治疗后的再捕获率和再治疗率：一项随机安慰剂对照停药研究的第104周结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2022-222731
Landewé, Robert B M; Poddubnyy, Denis; Rahman, Proton; Van den Bosch, Filip E; Bolce, Rebecca; Liu Leage, Soyi; Lisse, Jeffrey R; Park, So Young; Gensler, Lianne
关节炎
发表日期：2023
文献求助 收藏

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2

两项 III 期临床试验（SPIRIT-P1 和 SPIRIT-P2）表明，ixekizumab 对银屑病关节炎患者的中轴症状有影响。

期刊:Therapeutic Advances in Musculoskeletal Disease
影响因子:4.1
doi:10.1177/1759720X231189005
Deodhar, Atul; Gladman, Dafna; Bolce, Rebecca; Sandoval, David; Park, So Young; Leage, Soyi Liu; Nash, Peter; Poddubnyy, Denis
关节炎
银屑病
发表日期：2023
文献求助 收藏

Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H

在未接受过生物制剂类疾病修饰抗风湿药物治疗的银屑病关节炎患者中，无论银屑病严重程度如何，伊克珠单抗均显示出与阿达木单抗一致的疗效：SPIRIT-H2H 研究的 52 周事后分析结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00388-8
Kristensen, Lars-Erik; Okada, Masato; Tillett, William; Leage, Soyi Liu; El Baou, Celine; Sapin, Christophe; Bradley, Andrew J; Meszaros, Gabriella; Dutz, Jan P; de Vlam, Kurt
关节炎
银屑病
发表日期：2022
文献求助 收藏

Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial

在未接受过生物制剂治疗的活动性银屑病关节炎和中重度银屑病患者中，伊克珠单抗与阿达木单抗的疗效和安全性比较：随机SPIRIT-H2H试验的52周结果

期刊:Dermatology Practical & Conceptual
影响因子:2.3
doi:10.5826/dpc.1202a104
Reich, Kristian; Kristensen, Lars Erik; Smith, Saxon D; Rich, Phoebe; Sapin, Christophe; Leage, Soyi Liu; McKenzie, Robert; Schuster, Christopher; Riedl, Elisabeth; Gooderham, Melinda
关节炎
银屑病
发表日期：2022
文献求助 收藏

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)

对于已达到缓解的中轴型脊柱关节炎患者，继续使用 ixekizumab 治疗与停止治疗的疗效和安全性比较：一项安慰剂对照、随机停药研究 (COAST-Y) 的结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2020-219717
Landewé, Robert Bm; Gensler, Lianne S; Poddubnyy, Denis; Rahman, Proton; Hojnik, Maja; Li, Xiaoqi; Liu Leage, Soyi; Adams, David; Carlier, Hilde; Van den Bosch, Filip
关节炎
发表日期：2021
文献求助 收藏

Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials

更正：ixekizumab 在斑块状银屑病、银屑病关节炎和中轴型脊柱关节炎成人患者中的安全性：来自 21 项临床试验的数据

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keab566
Genovese, Mark C; Mysler, Eduardo; Tomita, Tetsuya; Papp, Kim A; Salvarani, Carlo; Schwartzman, Sergio; Gallo, Gaia; Patel, Himanshu; Lisse, Jeffrey R; Kronbergs, Andris; Leage, Soyi Liu; Adams, David H; Xu, Wen; Marzo-Ortega, Helena; Lebwohl, Mark G
银屑病
关节炎
发表日期：2021
文献求助 收藏

Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52

评估治疗对银屑病关节炎相关领域的影响：SPIRIT-H2H 研究第 24 周和第 52 周的启示

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-021-05891-5
Behrens, Frank; Leage, Soyi Liu; Sapin, Christophe; Baou, Celine El; De La Torre, Inmaculada; Meszaros, Gabriella; Schett, Georg; Combe, Bernard; van den Bosch, Filip; Gossec, Laure
关节炎
银屑病
发表日期：2021
文献求助 收藏

Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52

更正：衡量治疗对银屑病关节炎相关领域的影响：来自 SPIRIT-H2H 研究第 24 周和第 52 周的见解

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-021-05966-3
Behrens, Frank; Leage, Soyi Liu; Sapin, Christophe; El Baou, Celine; De La Torre, Inmaculada; Meszaros, Gabriella; Schett, Georg; Combe, Bernard; van den Bosch, Filip; Gossec, Laure
关节炎
银屑病
发表日期：2021
文献求助 收藏